The global erectile dysfunction
drugs market is expected to reach USD 3.2 billion by 2022 according to a new report by Grand View Research Inc.
affected 49.7 percent of the men in the study.A
The researchers found that the prevalence of indicators of low testosterone levels and erectile dysfunction
was 18.3 and 22.7 percent, respectively.
is sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity.
While the connection between T and erectile dysfunction
is not linear, the master androgen is still significantly involved in penile function in adults.
The discovery is a significant advancement in the understanding of the genetics underlying erectile dysfunction
About a third of erectile dysfunction
risk is linked to genetic factors.
The company's CF602 drug candidate previously demonstrated a robust positive effect in the treatment of erectile dysfunction
in preclinical studies.
(ED) is defined by the consistent or recurrent inability to attain or maintain penile erection adequate for sexual intercourse.1 Epidemiological studies have suggested that more than 30 million males in United States are affected by ED.2 QJ Zhang and his colleagues reported that the prevalence of ED is 26.1% in the three major cities of Beijing, Chongqing and Guangzhou in China.3 Penile erection is a complex process involving psychogenic and hormonal input.4 Endocrine disorders, hypogonadism, hyperprolactinemia and thyroid diseases, are common risk factors of ED.5,6 Previous studies have reported that in overt hypothyroidism, the ratio of ED reach up to 52.1% and moreover overt thyroid function failure adversely affects erectile function among males.7,8
breakthrough noninvasive medical therapy uses low-intensity shockwave therapy to enhance sexual performance as well as to treat Erectile Dysfunction
(ED) symptoms The GAINSWave protocols uses high-frequency acoustic waves to repair existing blood vessels and improve blood flow.
According to the company, thirty percent of the 30,000,000 patients suffering from erectile dysfunction
do not respond to drugs like Viagra, Cialis and Levitra, in part due to an underlying degeneration of the biological machinery needed to achieve erections.